UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial

Annals of allergy, asthma, & immunology, 2011-12, Vol.107 (6), p.529-537.e2

2011

Volltextzugriff (PDF)

Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate

Journal of rheumatology, 2012-04, Vol.39 (4), p.720

2012

Volltextzugriff (PDF)

Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritis

Journal of rheumatology, 2009-02, Vol.36 (2), p.422-426

2009

Volltextzugriff (PDF)

A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis

Journal of rheumatology, 2009-01, Vol.36 (1), p.174-182

2009

Volltextzugriff (PDF)

A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale

Clinical and Experimental Rheumatology, 2021-07, Vol.39 Suppl 131 (4), p.124-133

2021

Volltextzugriff (PDF)

Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study

Clinical gastroenterology and hepatology, 2006-02, Vol.4 (2), p.203-211

2006

Volltextzugriff (PDF)

Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature review

Rheumatology international, 2011-06, Vol.31 (6), p.749-756

2011

Volltextzugriff (PDF)

Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis

Journal of rheumatology, 2005-02, Vol.32 (2), p.366

2005

Volltextzugriff (PDF)

Dosing Celecoxib in Pediatric Patients With Juvenile Rheumatoid Arthritis

Journal of clinical pharmacology, 2012-08, Vol.52 (8), p.1134-1149

2012

Volltextzugriff (PDF)

Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis

Journal of rheumatology, 2002-01, Vol.29 (1), p.169

2002

Volltextzugriff (PDF)

Soluble adhesion molecules in pediatric rheumatic diseases

Journal of rheumatology, 2002-04, Vol.29 (4), p.832

2002

Volltextzugriff (PDF)

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

Arthritis & rheumatology (Hoboken, N.J.), 2012-05, Vol.64 (5), p.1487-1487

2012

Volltextzugriff (PDF)

Randomized placebo-controlled trial of the bradykinin B 2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial

Annals of allergy, asthma, & immunology, 2011-12, Vol.107 (6), p.529-537.e2

2011

Volltextzugriff (PDF)

Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Cerebrospinal Fluid in Lyme Neuroborreliosis

The Journal of infectious diseases, 1996-09, Vol.174 (3), p.623-627

1996

Volltextzugriff (PDF)

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo

Arthritis and rheumatism, 2009-07, Vol.60 (7), p.1895-1905

2009

Volltextzugriff (PDF)

Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis

Rheumatology international, 2007-05, Vol.27 (7), p.655-660

2007

Volltextzugriff (PDF)

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2023-09, Vol.75 (9), p.1608-1618

2023

Volltextzugriff (PDF)

Case 29-2002: A 17-Year-Old Boy with Acute Mitral Regurgitation and Pulmonary Edema

The New England journal of medicine, 2002-09, Vol.347 (12), p.921-928

2002

Volltextzugriff (PDF)

New drug therapies for the pediatric rheumatic diseases

Current opinion in rheumatology, 2001-09, Vol.13 (5), p.410-414

Bloom, Bradley J

2001

Volltextzugriff (PDF)

Neurocognitive abnormalities in children after classic manifestations of Lyme disease

The Pediatric infectious disease journal, 1998-03, Vol.17 (3), p.189-196

1998

Volltextzugriff (PDF)

Synovial fluid levels of E-selectin and intercellular adhesion molecule-1: relationship to joint inflammation in children with chronic arthritis

Rheumatology international, 2002-09, Vol.22 (5), p.175-177

2002

Volltextzugriff (PDF)

Case 14-1999: A Nine-Year-Old Girl with Fever and Cervical Lymphadenopathy

The New England journal of medicine, 1999-05, Vol.340 (19), p.1491-1497

1999

Volltextzugriff (PDF)

Efficacy and Safety of CE-224,535, an Antagonist of P2X 7 Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate

Journal of rheumatology, 2012-04, Vol.39 (4), p.720-727

2012

Volltextzugriff (PDF)

Macrophage activation is a key component in the pathogenesis of systemic juvenile idiopathic arthritis: Comment on the article by Blessing et al

Arthritis and rheumatism, 2007-11, Vol.56 (11), p.3877-3878

Bloom, Bradley J.

2007

Volltextzugriff (PDF)

Development of diabetes mellitus during etanercept therapy in a child with systemic‐onset juvenile rheumatoid arthritis

Arthritis and rheumatism, 2000-11, Vol.43 (11), p.2606-2608

Bloom, Bradley J.

2000

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(124)

Publikationsform

Artikel
(153)
Tagungsberichte
(3)

Sprache

Englisch
(156)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(105)
Life Sciences & Biomedicine
(58)
Humans
(55)
Physical Sciences
(41)
Astronomy & Astrophysics
(35)
Male
(35)
Female
(34)
Biological And Medical Sciences
(24)
Astronomy
(21)
Medical Sciences
(21)
Adolescent
(19)
Adult
(19)
Astrophysics, Cosmology And Astronomy
(19)
Child
(18)
Supernovae
(18)
Astrophysics
(17)
Exact Sciences And Technology
(16)
Rheumatology
(16)
Earth, Ocean, Space
(15)
Luminosity
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial

Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate

Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritis

A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis

A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale

Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study

Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature review

Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis

Dosing Celecoxib in Pediatric Patients With Juvenile Rheumatoid Arthritis

Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis

Soluble adhesion molecules in pediatric rheumatic diseases

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

Randomized placebo-controlled trial of the bradykinin B 2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial

Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Cerebrospinal Fluid in Lyme Neuroborreliosis

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo

Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

Case 29-2002: A 17-Year-Old Boy with Acute Mitral Regurgitation and Pulmonary Edema

New drug therapies for the pediatric rheumatic diseases

Neurocognitive abnormalities in children after classic manifestations of Lyme disease

Synovial fluid levels of E-selectin and intercellular adhesion molecule-1: relationship to joint inflammation in children with chronic arthritis

Case 14-1999: A Nine-Year-Old Girl with Fever and Cervical Lymphadenopathy

Efficacy and Safety of CE-224,535, an Antagonist of P2X 7 Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate

Macrophage activation is a key component in the pathogenesis of systemic juvenile idiopathic arthritis: Comment on the article by Blessing et al

Development of diabetes mellitus during etanercept therapy in a child with systemic‐onset juvenile rheumatoid arthritis

Suchergebnisse filtern